News
Bioclinica Announces Breakthrough AI Image Redaction Technology for Clinical Trials
New solution offers pharmaceutical and biotech companies a powerful tool for video, photo, and PDF redaction, ensuring compliance and patient privacy
Partnership allows sponsors to easily scale projects to streamline clinical trials
Bioclinica boosts digital trial credentials with Saliency buy
With the ink barely dry on its last merger agreement, clinical trial and imaging specialist Bioclinica is on an expansive drive once again, buying digital…
Bioclinica Acquires Saliency to Accelerate Digital Diagnostic Development
New AI integration dramatically speeds medical image interpretation and model creation within Bioclinica’s imaging platform
ERT and Bioclinica to Merge, Creating a Global Leader in Clinical Trial Endpoint Technology
ERT is a global market leader and innovator in clinical trial end-point data solutions, providing clinical study teams with higher-fidelity…
Cinven Portfolio Company Bioclinica to Merge with ERT
Combination of Bioclinica and ERT to create a leading independent provider of data and technology for use in clinical trials…
Bioclinica’s Client Services and Delivery Organization Led by Bradley Dean, SVP
A new Client Services and Delivery organization, led by Brad Dean as Senior Vice President, will allow for all facets of client management and solution…
Robert R. Ford, MD, Returns to Bioclinica
Dr. Ford, one of Bioclinica’s founders, returns as Senior Advisor, Chief Medical Officer Emeritus. In this role, Dr. Ford will share his medical expertise with…
Bioclinica’s Michael O’Neal, MD, Takes on Newly Expanded Chief Medical Officer Role
Dr. Mike O’Neal will lead the newly unified Medical and Scientific Affairs organization as Chief Medical Officer.
Bioclinica Partners with GI Reviewers in Developing Advanced Technologies
Bioclinica announces a strategic partnership with Daniel Mishkin, MD, and GI Reviewers, LLC to develop technology for the interpretation and analysis of colonoscopy videos in…